Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
University of Miami School of Medicine
Coral Gables, Florida
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 45
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Noriyuki Kasahara | Conflict of Interest | Tocagen, Inc | >$600,000 | 2018 |
| Joshua Hare | Conflict of Interest | Longeveron, LLC | $250,000 - $299,999 | 2017 |
| Joshua Hare | Conflict of Interest | Longeveron | $250,000 - $299,999 | 2018 |
| Claudio Soto | Conflict of Interest | Amprion, Inc. | $20,000 - $39,999 | 2019 |
| William Harbour | Conflict of Interest | Castle Biosciences | $20,000 - $39,999 | 2017 |
| Sulagna Banerjee | Conflict of Interest | Minneamrita Therapeutics | $10,000 - $19,999 | 2016 |
| Robert Knighton | Conflict of Interest | Carl Zeiss Meditec | $10,000 - $19,999 | 2016 |
| Salugna Banerjee | Conflict of Interest | Minneamrita Therapeutics | $10,000 - $19,999 | 2018 |
| Sulagna Banerjee | Conflict of Interest | Minneamrita Therapeutics | $10,000 - $19,999 | 2016 |
| Salugna Banerjee | Conflict of Interest | Minneamrita Therapeutics | $10,000 - $19,999 | 2018 |
| William Harbour | Conflict of Interest | Castle Biosciences | $10,000 - $19,999 | 2017 |
| Sulagna Banerjee | Conflict of Interest | Minneamrita Therapeutics | $10,000 - $19,999 | 2016 |
| Robert Levy | Conflict of Interest | Allergan | $5,000 - $9,999 | 2014 |
| Susanne Doblecki-Lewis | Conflict of Interest | Gilead Pharmaceuticals | $5,000 - $9,999 | 2019 |
| Rebecca Schule | Conflict of Interest | ViaGenetics, LLC | $5,000 - $9,999 | 2016 |
| Claudio Soto | Conflict of Interest | Amprion, Inc. | $0 - $4,999 | 2019 |
| Ashok Saluja | Conflict of Interest | Minneamrita Therapeutics | 2018 | |
| Joshua Hare | Conflict of Interest | Longeveron, LLC | 2017 | |
| Alice Tomei | Conflict of Interest | Converge Biotech | 2018 | |
| Sonia Yoo | Conflict of Interest | Resolve Ophthalmics | 2018 | |
| Stephan Zuchner | Conflict of Interest | ViaGenetics, LLC | 2016 | |
| Anthony Capobianco | Conflict of Interest | StemSynergy Therapeutics | 2018 | |
| Christopher Fraker | Conflict of Interest | Ophysio | 2019 | |
| Joshua Hare | Conflict of Interest | Biscayne Pharmaceuticals | 2017 | |
| Joshua Hare | Conflict of Interest | Longeveron | 2018 | |
| Siddarth Rawal | Conflict of Interest | Circulogix | 2018 | |
| Camillo Ricordi | Conflict of Interest | Ophysio | 2018 | |
| Ashok Saluja | Conflict of Interest | Minneamrita Therapeutics | 2016 | |
| Ashok Saluja | Conflict of Interest | Minneamrita Therapeutics | 2018 | |
| Hong Tian | Conflict of Interest | Everglades Biopharma | 2019 | |
| Joshua Hare | Conflict of Interest | Biscayne Pharmaceuticals | 2013 | |
| Joshua Hare | Conflict of Interest | Biscayne Pharmaceuticals | 2013 | |
| Mohammad Abou Shoush | Conflict of Interest | Resolve Ophthalmics | 2018 | |
| Yeon Anh | Conflict of Interest | RxMP Therapeutics | 2016 | |
| Sara Czaja | Conflict of Interest | i-Function | 2017 | |
| Richard Cote | Conflict of Interest | Circulogix | 2018 | |
| Juan Dominguez-Bendala | Conflict of Interest | Ophysio | 2018 | |
| Joshua Hare | Conflict of Interest | Biscayne Pharmaceuticals | 2017 | |
| Joshua Hare | Conflict of Interest | Vestion, Inc | 2013 | |
| Philip Harvey | Conflict of Interest | i-Function, Inc | 2017 | |
| Wenche Jy | Conflict of Interest | RxMP Therapeutics | 2016 | |
| Wei Li | Conflict of Interest | Everglades Biopharma | 2019 | |
| David Robbins | Conflict of Interest | StemSynergy Therapeutics | 2018 | |
| Ashok Saluja | Conflict of Interest | Minneamrita Therapeutics | 2016 | |
| Ashok Saluja | Conflict of Interest | Minneamrita Therapeutics | 2016 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.